clinical trials investigating venetoclax combinations for aml
Published 6 years ago • 246 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
2:24
the latest clinical trials into novel aml therapies
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:27
quizartinib, venetoclax, and decitabine in patients with flt3-itd aml: a phase i/ii trial
-
4:21
hovon 141/vision trial update: mrd-guided venetoclax ibrutinib treatment for r/r cll
-
6:43
key highlights in cll: clinical trial updates & the role of combination therapies and novel btkis
-
11:42
thalassemia highlights at ash 2023: novel therapies, trial updates & the value of precision medicine
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
3:24
currently available approaches for treating cll
-
0:54
study design for persist-2 and other upcoming trials of pacritinib
-
1:16
considering enrolment in clinical trials for patients with amyloidosis
-
1:32
novel agent combinations: the future of cll
-
1:01
recent and future changes in the landscape of aml: the addition of venetoclax and mrd eradication
-
1:11
treatment options for patients with cll after failure of covalent btk inhibitors and venetoclax
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
2:59
clinical trial updates and time-limited therapy in cll
-
2:14
updates on the smart stop trial: the potential for a chemo-free regimen in the frontline for dlbcl
-
1:54
a novel clinical trial endpoint for acute gvhd
-
0:49
the future of inhibiting bcl2 for the treatment of t-all
-
2:00
obinutuzumab, ibrutinib, and venetoclax in high-risk cll: the cll2-give and cll13 trials
-
2:23
emerging therapies for ebv-driven ptld & insights into the allele trial